Inventor · disambiguated record
Roeland Quirinus Jozef Schaapveld
Also filed as: SCHAAPVELD ROELAND QUIRINUS JOZEF
9 granted patents·4 pending applications·17 citations·filing 2012–2021
82Inventor score
Top patents by PatentIndex Score
13 records- 0181US10023868B2MiRNA for treating diseases and conditions associated with neo-angiogenesisINTERNA TECH B V·Filed 2016·Granted Jul 17, 2018·3 cites·15 claims
- 0273US9441222B2MiRNA for treating diseases and conditions associated with neo-angiogenesisINT TECH B V·Filed 2013·Granted Sep 13, 2016·3 cites·5 claims
- 0371US10201556B2Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathwayINTERNA TECH B V·Filed 2013·Granted Feb 12, 2019·4 cites·10 claims
- 0471US9944932B2MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMTINTERNA TECH B V·Filed 2015·Granted Apr 17, 2018·2 cites·14 claims
- 0569US9682095B2MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathwayINT TECH B V·Filed 2013·Granted Jun 20, 2017·3 cites·16 claims
- 0661US9161947B2MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMTSCHAAPVELD ROELAND QUIRINUS JOZEF·Filed 2012·Granted Oct 20, 2015·2 cites·20 claims
- 0747US2023136088A1miRNA-193a for Promoting Immunogenic Cell DeathINTERNA TECH B V·Filed 2021·Application pending·0 cites
- 0844US2022275368A1New treatments involving mirna-193aINTERNA TECH B V·Filed 2020·Application pending·0 cites
- 0943US10583149B2MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathwayINTERNA TECH B V·Filed 2017·Granted Mar 10, 2020·0 cites·16 claims
- 1039US10174314B2MiRNA for treating head and neck cancerINTERNA TECH B V·Filed 2012·Granted Jan 8, 2019·0 cites·2 claims
- 1137US11497762B2MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generationINTERNA TECH B V·Filed 2018·Granted Nov 15, 2022·0 cites·9 claims
- 1237US2021038732A1Anticancer microrna and lipid formulations thereofINTERNA TECH B V·Filed 2019·Application pending·0 cites
- 1332US2017130277A1Biomarker for colorectal cancerSTICHTING VU-VUMC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →